WN1703 alleviates gout symptoms via inflammatory signaling pathways in an acute gout rat model
We previously synthesized the xanthine oxidoreductase (XOR) inhibitor WN1703. In addition to showing XOR inhibitory effects, WN1703 also showed anti-inflammatory effects in a rat hyperuricemia model. Here, we studied WN1703's anti-inflammatory effects on gout and explored the underlying mechanisms....
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier
2024-12-01
|
| Schriftenreihe: | Pharmaceutical Science Advances |
| Schlagworte: | |
| Online-Zugang: | http://www.sciencedirect.com/science/article/pii/S2773216924000059 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
